Compare Abbott Laboratories (ABT) vs YieldMax AMZN Option Income Strategy ETF (AMZY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs YieldMax AMZN Option Income Strategy ETF — how do they compare? Abbott Laboratories trades at $95.37 (market cap $166.94B), while YieldMax AMZN Option Income Strategy ETF trades at $10.68. The key difference: Abbott Laboratories pays a 2.63% dividend while YieldMax AMZN Option Income Strategy ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ABT | AMZY | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $136.62 | $16.61 |
52-Week Low | $82.57 | $10.26 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
AMZY trades at $10.74, up 0.51% today, with a bearish technical signal from moving averages. The ETF generates high weekly dividends but faces scrutiny over net asset value erosion. Recent news highlights consistent distribution announcements alongside analyst downgrades citing structural risks in its synthetic option strategy relative to Amazon's performance.
The outlook is cautious due to inevitable NAV erosion despite high yield, with total returns lagging Amazon. Risks include amplified downside exposure and unsustainable payouts. Investors prioritizing income may find appeal, but long-term capital appreciation appears constrained by the fund's design.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About YieldMax AMZN Option Income Strategy ETF
AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.
Read more on AMZY →
